ES2148617T3 - Reactivos perfeccionados para un inmunoensayo de cannabinoides. - Google Patents

Reactivos perfeccionados para un inmunoensayo de cannabinoides.

Info

Publication number
ES2148617T3
ES2148617T3 ES96104776T ES96104776T ES2148617T3 ES 2148617 T3 ES2148617 T3 ES 2148617T3 ES 96104776 T ES96104776 T ES 96104776T ES 96104776 T ES96104776 T ES 96104776T ES 2148617 T3 ES2148617 T3 ES 2148617T3
Authority
ES
Spain
Prior art keywords
sup
linear
branched
rent
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96104776T
Other languages
English (en)
Inventor
Raymond Albert Hui
Steven Mark Rosen
Salvatore Joseph Salmone
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Application granted granted Critical
Publication of ES2148617T3 publication Critical patent/ES2148617T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Anesthesiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA PRESENTE INVENCION PROPORCIONA: DERIVADOS DE BENZOPIRANO NUEVOS DE FORMULA DONDE R{SUP,1} ES UN GRUPO ALQUILO LINEAL O RAMIFICADO QUE TIENE DE 1 A 9 ATOMOS DE CARBONO; R{SUP,2} Y R{SUP,3} SE SELECCIONAN INDEPENDIENTEMENTE DE UN ALQUILO INFERIOR LINEAL O RAMIFICADO QUE PUEDE SUSTITUIRSE POR UNO O MAS DE LOS SIGUIENTES GRUPOS FUNCIONALES: -OH, -COR{SUP,4}, -NR{SUP,5}R{SUP,6}, -SH, -C(=NH)OR{SUP,7}, -CHO, O =O SIEMPRE QUE AL MENOS UNO DE R{SUP,2} O R{SUP,3} SE SUSTITUYA POR UNO DE LOS GRUPOS FUNCIONALES ANTES DESCRITOS; R{SUP,4} ES -OH O UN GRUPO DE SALIDA; R{SUP,5} Y R{SUP,6} SE SELECCIONAN INDEPENDIENTEMENTE DEL GRUPO QUE INCLUYE H Y ALQUILO INFERIOR LINEAL O RAMIFICADO; R{SUP,7} ES UN ALQUILO BAJO LINEAL O RAMIFICADO; Y A,B, Y C SON INDEPENDIENTEMENTE ENLACES SENCILLOS O DOBLES, SIEMPRE QUE CUANDO B ES UN ENLACE DOBLE, ENTONCES A Y C SEAN ENLACES DOBLES, ANTICUERPOS NUEVOS PRODUCIDOS MEDIANTE LA UTILIZACION DE DICHOS DERIVADOS DE BENZOPIRANO, METODOS PARA PRODUCIR ESTOS ANTICUERPOS E INMUNOENSAYOS QUE UTILIZAN ESTOS ULTIMOS PARA LA DETECCION DE METABOLITOS DE TETRAHIDROCANABINOL EN MUESTRAS DE SANGRE U ORINA.
ES96104776T 1995-04-05 1996-03-26 Reactivos perfeccionados para un inmunoensayo de cannabinoides. Expired - Lifetime ES2148617T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/417,331 US5817766A (en) 1995-04-05 1995-04-05 Reagents for a cannabinoid immunoassay

Publications (1)

Publication Number Publication Date
ES2148617T3 true ES2148617T3 (es) 2000-10-16

Family

ID=23653524

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96104776T Expired - Lifetime ES2148617T3 (es) 1995-04-05 1996-03-26 Reactivos perfeccionados para un inmunoensayo de cannabinoides.

Country Status (7)

Country Link
US (1) US5817766A (es)
EP (1) EP0736529B1 (es)
JP (2) JP4229990B2 (es)
AT (1) ATE194339T1 (es)
CA (1) CA2172663C (es)
DE (1) DE69609108T2 (es)
ES (1) ES2148617T3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2770828B2 (ja) * 1997-03-21 1998-07-02 松下電器産業株式会社 文書出力装置
WO2000066260A1 (en) * 1999-04-28 2000-11-09 Toray Industries, Inc. Materials for eliminating cannabinoids and columns for the elimination of cannabinoids with the use of the same
US6686209B2 (en) 2001-03-12 2004-02-03 Lifepoint, Inc. Reagents for detecting cannabinoids
EP1499306A4 (en) * 2002-04-12 2007-03-28 Merck & Co Inc BICYCLIC AMIDE
US8288544B2 (en) 2003-07-01 2012-10-16 Roche Diagnostics Operations, Inc. Electrochemical affinity biosensor system and methods
US20060051824A1 (en) * 2004-09-03 2006-03-09 Haoyun An Tetrahydrocannabinoid antigens and method of use
US7465586B2 (en) * 2004-11-03 2008-12-16 Labone, Inc. Oral detection test for cannabinoid use
KR100794515B1 (ko) 2005-07-12 2008-01-16 제일약품주식회사 항염증 활성을 갖는 크로멘-2-온 모핵 히드록사민 산유도체, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
WO2007008037A1 (en) * 2005-07-12 2007-01-18 Jeil Pharmaceutical Co., Ltd. Novel chromen-2-one based hydroxamic acid derivatives having anti-inflammatory activity, the preparation thereof and a composition containing the same for treating inflammatory disease
US9435817B2 (en) 2011-02-14 2016-09-06 Randox Laboratories Limited Detection of synthetic cannabinoids
US9441033B2 (en) * 2011-02-14 2016-09-13 Randox Laboratories Limited Detection of synthetic cannabinoids
GB201102544D0 (en) 2011-02-14 2011-03-30 Randox Lab Ltd Assay
US9434687B2 (en) 2011-02-14 2016-09-06 Randox Laboratories Limited Detection of synthetic cannabinoids
US10408786B2 (en) 2012-06-14 2019-09-10 ChemiSensor, LLP Distributable chemical sampling and sensing system
EP2698384A1 (en) * 2012-08-14 2014-02-19 Randox Laboratories Ltd. Detection of synthetic cannabinoids
EP2698385A1 (en) * 2012-08-14 2014-02-19 Randox Laboratories Ltd. Detection of synthetic cannabinoids
EP2698383B1 (en) * 2012-08-14 2020-11-25 Randox Laboratories Ltd. Detection of synthetic Cannabinoids
US9817007B2 (en) * 2014-03-05 2017-11-14 John Scott Perez Method and apparatus for real-time detection of human cannabinoid intoxication
MA39708A (fr) 2014-03-27 2021-03-31 Bird Rock Bio Inc Anticorps qui se lient au récepteur cannabinoïde 1 (cb1) humain
BR112018006633A2 (en) 2015-09-30 2018-10-23 Bird Rock Bio, Inc. antibodies that bind to human cannabinoid receptor 1 (cb1)
CN115327126B (zh) * 2022-08-10 2025-06-03 郑州左安检测科技有限公司 一种检测大麻二酚的时间分辨荧光微球免疫层析试纸条及其制备方法和应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2354492A (en) * 1941-11-26 1944-07-25 Adams Roger Marihuana active compound
US4329281A (en) * 1978-06-05 1982-05-11 Hoffmann-La Roche Inc. Hapten compositions
US4438207A (en) * 1979-09-26 1984-03-20 Hoffmann-La Roche Inc. Radioimmunoassay for cannabinoids
US5223441A (en) * 1986-10-09 1993-06-29 Syntex (U.S.A.) Inc. Receptors for immune complexes
US4833073A (en) * 1987-01-27 1989-05-23 Hoffmann-La Roche Inc. Immunoassay for tetrahydrocannabinol metabolites
US5264373A (en) * 1987-02-17 1993-11-23 Abbott Laboratories Fluorescence polarization immunoassay for tetrahydrocannabinoids
US5144030A (en) * 1987-02-17 1992-09-01 Abbott Laboratories Fluorescene polarization immunoassay for tetrahydrocannabinoids
DE3855490T2 (de) * 1987-02-17 1997-03-27 Abbott Lab Fluoreszenz-Polarisationsimmunotest für Tetrahydrocannabinoide
JPS63257178A (ja) * 1987-04-13 1988-10-25 Nec Home Electronics Ltd コンパクト型蛍光ランプ
JPS63257177A (ja) * 1987-04-13 1988-10-25 Hitachi Ltd 超高圧水銀灯
JPH01273582A (ja) * 1988-04-26 1989-11-01 Matsushita Electric Ind Co Ltd モノクローナル抗体産生細胞ライン及びモノクローナル抗体及び免疫原
JP2600850B2 (ja) * 1988-10-04 1997-04-16 松下電器産業株式会社 テトラヒドロカンナビノール誘導体
US5237057A (en) * 1992-04-06 1993-08-17 Biosite Diagnostics, Inc. Tetrahydrocannabinol derivatives and protein and polypeptide tetrahydrocannabinol derivative conjugates and labels
US5315015A (en) * 1992-11-10 1994-05-24 Hoffmann-La Roche Inc. Compounds having improved fluorescence in fluorescence polarization immunoassays and immunoassays utilizing same

Also Published As

Publication number Publication date
JPH08283258A (ja) 1996-10-29
DE69609108D1 (de) 2000-08-10
JP2009051839A (ja) 2009-03-12
ATE194339T1 (de) 2000-07-15
EP0736529B1 (en) 2000-07-05
JP4229990B2 (ja) 2009-02-25
CA2172663C (en) 2008-12-02
EP0736529A1 (en) 1996-10-09
CA2172663A1 (en) 1996-10-06
DE69609108T2 (de) 2001-03-22
US5817766A (en) 1998-10-06

Similar Documents

Publication Publication Date Title
ES2148617T3 (es) Reactivos perfeccionados para un inmunoensayo de cannabinoides.
ES2060610T3 (es) Nuevos derivados del cannabinol e inmunoensayo perfeccionado.
PT852243E (pt) Polioxido de etileno tendo um residuo de um sacarideo numa das extremidades e um grupo funcional diferente na outra extremidade e processo para a producao do mesmo
NO875476D0 (no) Elektrokjemiluminiscente proever.
MX168720B (es) Composicion para impartir al cabello propiedades de acondicionamiento mejoradas
ES2036551T3 (es) Compuestos heterociclicos.
ES2171676T3 (es) Inmunoensayos por quimioluminiscencia para la deteccion de anticuerpos.
PT82682B (pt) Processo para a preparacao de derivados da quinazolina e de composicoes farmaceuticas que os contem
BR9707060A (pt) Métodos e composições para detectar o ligamento de par ligante usando indicador não-fluorescente.
EA199900474A1 (ru) Предупреждение потери и восстановление костной массы некоторыми агонистами простагландина
ES2005059B3 (es) Nuevo procedimiento de preparacion de fibratos.
ES2168953B1 (es) Derivados de oxima y su uso como acidos latentes
DK0660936T3 (da) Op-konverterende reportermolekyle til biologiske og andre assays under anvendelse af laserexcitationsteknik
MX9207137A (es) Nuevos oligodesoxirribonucleotidos, que tienen una actividad anti-isquemica, y metodos para su preparacion
ES534959A0 (es) Procedimiento para la preparacion de derivados de oligoglucosido
ATE185899T1 (de) Chemilumineszente zusammensetzung, enthaltend kationische tenside oder polymere und 4'hydroxyacetanilid, testkits und deren verwendung in analytischen verfahren
BR9805031A (pt) Compostos de naftaleno, processo para sua preparação e composições farmacêuticas contendo os mesmos.
ES539668A0 (es) Procedimiento para la preparacion de nuevas 5,11-dihidro-6h-dibenzo (b,e)azepin-6-onas sustituidas
NO911880L (no) Derivater av biologisk aktive molekyler, samt analysesettfor bestemmelse av mediatorer.
NO20006109L (no) Analytisk metode som benytter multippel virusmerking
ES8104791A1 (es) Procedimiento para la preparacion de bis-amidas de acidos 5-amino-2,4,6-triyodo-isoftalicos
AR001813A1 (es) Derivados de cromona procedimiento para prepararlos y las composiciones farmacéutica que los contienen
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
BR9801085A (pt) Processo para a preparação de moenomicina a.
AR241024A1 (es) Composicion de peroxido de hidrogeno acuoso apropiada para dilucion,para formar composiciones detergentes liquidas o composiciones de blanqueo,que consiste esencialmente en (a) de 20 a 35% en peso, en base a la composicion , de peroxido de hidrogeno,(b)

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 736529

Country of ref document: ES